DAIR for Infected Total Hip Arthroplasty - Does the Operative Approach Influence the Functional Result?
Debridement, Antibiotics and Implant Retention (DAIR) for Infected Total Hip Arthroplasty- Does the Operative Approach Influence the Functional Result?
Sponsor: Haukeland University Hospital
Listed as NCT03161990, this observational or N/A phase trial focuses on Arthroplasty Complications and Hip Prosthesis Infection and remains completed. Sponsored by Haukeland University Hospital, it has been updated 8 times since 2018, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jul 2019 — Jan 2021 [monthly]
Completed
Status: Enrolling By Invitation → Completed
-
Aug 2018 — Jul 2019 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
▶ Show 3 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Haukeland University Hospital
- University Hospital, Akershus
For direct contact, visit the study record on ClinicalTrials.gov .